LPFFD Pep-LNP
Cat. No.: TDLD-0126-LD111
LPFFD Pep-LNP
LPFFD Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered for efficient targeted drug delivery. Featuring the LPFFD peptide, it targets specific receptors to enhance therapeutic cargo delivery with improved stability and biocompatibility via PEGylation. Applications include targeted therapeutics development and receptor-mediated delivery studies. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | LPFFD Peptide |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
DRLDS Pep-LNP (TDLD-0126-LD82)
MMP2 Pep-LNP (TDLD-0126-LD116)
HAIYPRH Pep-LNP (TDLD-0126-LD161)
CREKA Pep-LNP (TDLD-0126-LD156)
FYLEHPSGGLAVC Pep-LNP (TDLD-0126-LD87)
VHPKQHRGGSKGC Pep-LNP (TDLD-0126-LD149)
GRADSP Pep-LNP (TDLD-0126-LD97)
Targeted CD7 Ab-LNP (TDLD-0825-LD67)
Online Inquiry
